Zone 1 lidocaine cream recalled because stability data does not support expiry
HTO Nevada, trading as Kirkman, is recalling one lot of Maximum Zone 1 4% Lidocaine Cream because the stability data does not support the labeled expiry date.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Rubric level 2 covers minor labelling errors: the fault is an expiry date the stability data does not support, and the source describes no hazard, illness or injury.
Plain-English summary
HTO Nevada Inc., trading as Kirkman, is recalling MAXIMUM ZONE 1 4% Lidocaine Cream in 1/2 oz bottles, distributed by Dermal Source of Portland, Oregon, NDC 80069-014. About 178 bottles were distributed nationwide within the United States. The FDA has classified this recall as Class II.
The recall was initiated because the stability data does not support the expiry date. The source record does not describe a specific hazard, illness or injury.
Affected product is lot 807CP-0003 with an expiry date of 07/31/2026.
Users can identify affected product by the NDC and lot number above, and may contact HTO Nevada Inc. for further information.
The recalled product
- Product
- MAXIMUM, ZONE 1, 4% Lidocaine Cream, 1/2 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-014.
- Manufacturer
- HTO Nevada Inc. dba Kirkman
- Category
- Drug — Topical anaesthetic
- Hazard
- stability-failure
- expiry-dating
- labelling-error
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 807CP-0003
- Exp. Date 07/31/2026.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22